#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hypertriglyceridaemia Central nervous system neoplasm Pneumonia Neuroendocrine cell hyperplasia of infancy Congenital leptin deficiency Fibrosarcoma metastatic Congenital disorder of glycosylation Non-Hodgkin's lymphoma Crigler-Najjar syndrome Dedifferentiated liposarcoma Nephropathy Oropharyngeal cancer recurrent Angiosarcoma Angiosarcoma metastatic Marginal zone lymphoma refractory More trials…

    Learn about Rare Diseases

    Langerhans’ cell histiocytosis – Treatment Glycogen storage disease type I – Treatment Extranodal marginal zone B-cell lymphoma (MALT type) – Trials in Disease Osteosarcoma recurrent – Trials in Disease Carcinoid syndrome – Treatment Hereditary neuropathic amyloidosis – Diagnostics Idiopathic inflammatory myopathy – Life with Disease Hypereosinophilic syndrome – Trials in Disease Mastocytosis – Treatment Mantle cell lymphoma refractory More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vib1116 Cefixime Solrikitug Mps-200 Emraclidine KETOROLAC TROMETAMOL Ab-1002 Bepranemab Human Serum Albumin 5% Follitropin Beta Gr0015 534 IADADEMSTAT Afatinib Losartan Gfh925 Oregovomab Bosutinib Omo-103 AZD4360 More therapies…

    Learn about Your Condition

    Infection Paresis Von Hippel-Lindau disease Angiosarcoma metastatic Frontotemporal dementia Diabetic foot Naevus flammeus Cortical dysplasia Osteogenesis imperfecta Hypotransferrinaemia Haemolytic uraemic syndrome Obliterative bronchiolitis Stem cell transplant Palpitations Parkinson's disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Sentinel Lymph Node Technique in Early-Stage Ovarian Cancer Using Pertechnetate (99mTc) Sodium, Human Serum Albumin, and Indocyanine Green

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Human Serum Albumin
    • Pertechnetate (99Mtc) Sodium
    • Indocyanine Green
    Spain

  • Evaluating Citrulline, Folic Acid, Vericiguat, and Tadalafil Combination for Patients with Treatment-Resistant High Blood Pressure

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hypertension
    Investigated Drugs:
    • Folic Acid
    • Tadalafil
    • Vericiguat
    Sweden

  • Study on the Safety and Effects of EIK1004 for Patients with Advanced Solid Tumors

    Recruiting

    2 1 1
    Investigated Diseases:
    • Neoplasm
    Denmark France Portugal Spain

  • Reduced Immunosuppression Therapy Trial for Elderly Kidney Transplant Recipients with End-Stage Renal Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • End stage renal disease
    Investigated Drugs:
    • Basiliximab
    • Mycophenolate Sodium
    • Lidocaine Hydrochloride Monohydrate
    Spain

  • Evaluation of Botulinum Toxin Injections for Women with Severe Primary Dysmenorrhea Unresponsive to First-Line Treatments

    Recruiting

    3 1 1
    Investigated Drugs:
    • Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
    France

  • Study of Bleximenib, Venetoclax, and Azacitidine Treatment for Newly Diagnosed Acute Myeloid Leukemia Patients Ineligible for Intensive Chemotherapy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • BLEXIMENIB
    • Azacitidine
    • Venetoclax
    Austria Belgium Czechia Denmark France Germany +6
Previous Page
1 … 169 170 171 172 173 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!